Back to results
US 9,867,816 B2Granted
PPARγ agonists for treatment of multiple sclerosis
AssigneeInteKrin Therapeutics, Inc.
InventorDavid Weinstein
Life of this patent
Estimating the term…
Abstract
Methods of treatment of multiple sclerosis (MS) with PPARγ agonists, and in particular with the compound of formula (I) known as INT131:
Claims7
A method of treating grey matter atrophy in a patient in need thereof comprising administering to said patient at regular dosing intervals a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I),
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.